Blog: Blog2

GPCR News

Feb 28, 20221 min read

Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology

March 2022 "Explicyte grants Domain Therapeutics exclusivity on data related to GPCR implicated in immunoresistance, to develop first-in...